Senthil K Chinnakannan

5PUBLICATIONS
45CO-AUTHORS
Nanotoxicology, health and safetyInnate immunityMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 21, 2022
A pan-genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice.

Timothy Donnison, Joey McGregor, Senthil Chinnakannan

|Apr 07, 2021
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses.

Ane Ogbe, Barbara Kronsteiner, Donal T Skelly

|Mar 22, 2021
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel.

Emily R Adams, Mark Ainsworth, Rekha Anand

|Jul 21, 2017
Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus Challenge.

Claire M Tully, Senthil Chinnakannan, Caitlin E Mullarkey

Pageof 1